Investor Presentation for the quarter and financial year ended March 31, 2026

Cfo Debt Reduction RoadmapInvestor Communications View source PDF

DCW · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.3%1-day move

₹50.45

prior close

₹51.34

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.0+0.6+1.7+2.6+2.3+1.2-1.2-6.1-4.9-7.0-4.2-8.9+0.3—

Up moveDown movePending

AI summary

DCW Ltd reported strong FY26 results with revenue of INR 21,436 Mn (+7.2% YoY) and PAT of INR 482 Mn, which more than doubled (+60.1% YoY). EBITDA margins improved to 10.34% from 9.66% in FY25. The company achieved highest-ever sales volumes in CPVC, SIOP, and Synthetic Rutile. Gross debt reduced significantly by INR 1,500 Mn to INR 2,758 Mn, with Net Debt/Equity at a healthy 0.07. Specialty Chemicals contributed 28% to revenue (up from 0.5% in FY16), though segment EBITDA margins contracted to 29.7% from 35.3% due to lower CPVC realizations. Basic Chemicals segment recovered from breakeven to 2.4% margin. The 5-year PAT CAGR stands at an impressive 66%.

Likely market impact

The company's strategic shift toward specialty chemicals is showing results with strong profitability growth and improved margins, while significant debt reduction strengthens the balance sheet. However, margin pressure in the specialty chemicals segment from lower CPVC realizations may limit upside in the near term.